Equities

PuraPharm Corp Ltd

PuraPharm Corp Ltd

Actions
  • Price (HKD)0.67
  • Today's Change0.00 / 0.00%
  • Shares traded22.50k
  • 1 Year change-37.96%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in HKDIncome statement in HKDView more

Year on year PuraPharm Corp Ltd had revenues fall -9.20% from 448.07m to 406.86m, though the company grew net income from a loss of 120.21m to a smaller loss of 106.08m.
Gross margin51.97%
Net profit margin-20.77%
Operating margin-12.63%
Return on assets-10.08%
Return on equity-50.23%
Return on investment-30.69%
More ▼

Cash flow in HKDView more

In 2023, cash reserves at PuraPharm Corp Ltd fell by 55.71m. However, the company earned 79.61m from its operations for a Cash Flow Margin of 19.57%. In addition the company used 18.20m on investing activities and also paid 122.39m in financing cash flows.
Cash flow per share-0.0967
Price/Cash flow per share--
Book value per share0.3296
Tangible book value per share0.2017
More ▼

Balance sheet in HKDView more

PuraPharm Corp Ltd has a Debt to Total Capital ratio of 75.97%, a higher figure than the previous year's 29.29%.
Current ratio0.5992
Quick ratio0.3116
Total debt/total equity3.16
Total debt/total capital0.7597
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.